Home › Trial NCT00005601
Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
- Trial IDNCT00005601
- StatusCompleted
- PhasePhase 2
- Study typeInterventional
- SponsorAlliance for Clinical Trials in Oncology
- Enrollment58
- Start date2000-10
- ConditionsLymphoma
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.